- Home
- CRMD vs BBDC Comparison
CRMD vs BBDC Comparison
Compare CRMD & BBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- BBDC
- Stock Information
- Founded
- CRMD 2006
- BBDC 2006
- Country
- CRMD United States
- BBDC United States
- Employees
- CRMD N/A
- BBDC N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- BBDC Diversified Financial Services
- Sector
- CRMD Health Care
- BBDC Finance
- Exchange
- CRMD Nasdaq
- BBDC Nasdaq
- Market Cap
- CRMD 876.7M
- BBDC 946.4M
- IPO Year
- CRMD 2010
- BBDC 2007
- Fundamental
- Price
- CRMD $9.79
- BBDC $8.92
- Analyst Decision
- CRMD Strong Buy
- BBDC Buy
- Analyst Count
- CRMD 7
- BBDC 3
- Target Price
- CRMD $17.43
- BBDC $9.67
- AVG Volume (30 Days)
- CRMD 3.1M
- BBDC 523.7K
- Earning Date
- CRMD 11-12-2025
- BBDC 11-06-2025
- Dividend Yield
- CRMD N/A
- BBDC 11.72%
- EPS Growth
- CRMD N/A
- BBDC N/A
- EPS
- CRMD 2.25
- BBDC 0.96
- Revenue
- CRMD $214,303,672.00
- BBDC $281,866,000.00
- Revenue This Year
- CRMD $565.64
- BBDC N/A
- Revenue Next Year
- CRMD $46.09
- BBDC N/A
- P/E Ratio
- CRMD $4.30
- BBDC $9.20
- Revenue Growth
- CRMD 1647.67
- BBDC N/A
- 52 Week Low
- CRMD $5.60
- BBDC $7.66
- 52 Week High
- CRMD $17.43
- BBDC $10.85
- Technical
- Relative Strength Index (RSI)
- CRMD 38.57
- BBDC 49.43
- Support Level
- CRMD $9.45
- BBDC $8.61
- Resistance Level
- CRMD $10.40
- BBDC $9.01
- Average True Range (ATR)
- CRMD 0.68
- BBDC 0.15
- MACD
- CRMD -0.14
- BBDC -0.01
- Stochastic Oscillator
- CRMD 13.66
- BBDC 48.84
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.